DBV Technologies   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Bagneux France (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2010
NCT01170286
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

DBV Technologies